Literature DB >> 25631495

microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.

Jen N Goh1,2, Ser Y Loo1,3,4, Arpita Datta3, Kodappully S Siveen2, Wei N Yap1,2, Wanpei Cai1,2, Eun M Shin1, Chao Wang1,2, Ji E Kim1, Maurice Chan5, Arun M Dharmarajan6, Ann S-G Lee3,5,7, Peter E Lobie1,2,8, Celestial T Yap3,8, Alan P Kumar1,2,6,8,9.   

Abstract

A large number of etiological factors and the complexity of breast cancers present challenges for prevention and treatment. Recently, the emergence of microRNAs (miRNAs) as cancer biomarkers has added an extra dimension to the 'molecular signatures' of breast cancer. Bioinformatic analyses indicate that each miRNA can regulate hundreds of target genes and could serve functionally as 'oncogenes' or 'tumour suppressor' genes, and co-ordinate multiple cellular processes relevant to cancer progression. A number of studies have shown that miRNAs play important roles in breast tumorigenesis, metastasis, proliferation and differentiation of breast cancer cells. This review provides a comprehensive overview of miRNAs with established functional relevance in breast cancer, their established target genes and resulting cellular phenotype. The role and application of circulating miRNAs in breast cancer is also discussed. Furthermore, we summarize the role of miRNAs in the hallmarks of breast cancer, as well as the possibility of using miRNAs as potential biomarkers for detection of breast cancer.
© 2015 Cambridge Philosophical Society.

Entities:  

Keywords:  biomarkers; breast cancer; cancer hallmarks; circulating miRNA; microRNA

Mesh:

Substances:

Year:  2015        PMID: 25631495     DOI: 10.1111/brv.12176

Source DB:  PubMed          Journal:  Biol Rev Camb Philos Soc        ISSN: 0006-3231


  35 in total

Review 1.  Exploiting microRNAs As Cancer Therapeutics.

Authors:  Tamsin Robb; Glen Reid; Cherie Blenkiron
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

2.  Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217.

Authors:  Jason J Northey; Alexander S Barrett; Irene Acerbi; Mary-Kate Hayward; Stephanie Talamantes; Ivory S Dean; Janna K Mouw; Suzanne M Ponik; Jonathon N Lakins; Po-Jui Huang; Junmin Wu; Quanming Shi; Susan Samson; Patricia J Keely; Rita A Mukhtar; Jan T Liphardt; John A Shepherd; E Shelley Hwang; Yunn-Yi Chen; Kirk C Hansen; Laurie E Littlepage; Valerie M Weaver
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

Review 3.  miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development.

Authors:  Nina Petrović
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

4.  MiR-556-5p modulates migration, invasion, and epithelial-mesenchymal transition in breast cancer cells via targeting PTHrP.

Authors:  Rongjun Zhou; Zhen Luo; Guanqun Yin; Lanting Yu; Hao Zhong
Journal:  J Mol Histol       Date:  2022-01-09       Impact factor: 2.611

Review 5.  Small molecules with huge impacts: the role of miRNA-regulated PI3K pathway in human malignancies.

Authors:  Bahareh Kashani; Zahra Zandi; Vahid Kaveh; Atieh Pourbagheri-Sigaroodi; Seyed H Ghaffari; Davood Bashash
Journal:  Mol Biol Rep       Date:  2021-10-23       Impact factor: 2.316

Review 6.  Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer.

Authors:  Xue Hu; Qiang Zhang; Wanying Xing; Wan Wang
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

7.  Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.

Authors:  Guodong Li; Lei Yao; Jinning Zhang; Xinglong Li; Shuwei Dang; Kai Zeng; Yuhui Zhou; Feng Gao
Journal:  Tumour Biol       Date:  2015-12-17

Review 8.  Roles for miRNAs in endocrine resistance in breast cancer.

Authors:  Penn Muluhngwi; Carolyn M Klinge
Journal:  Endocr Relat Cancer       Date:  2015-10       Impact factor: 5.678

9.  MicroRNA-4491 enhances cell proliferation and inhibits cell apoptosis in non-small cell lung cancer via targeting TRIM7.

Authors:  Fei Han; Gang Chen; Yi Guo; Bo Li; Yanlong Sun; Xiangqian Qi; Hanji Tian; Xinfei Zhao; Hongguang Zhang
Journal:  Oncol Lett       Date:  2021-06-07       Impact factor: 2.967

10.  miR-142-3p Modulates Cell Invasion and Migration via PKM2-Mediated Aerobic Glycolysis in Colorectal Cancer.

Authors:  JunYu Ren; Wenliang Li; Guoqing Pan; Fengchang Huang; Jun Yang; Hongbin Zhang; Ruize Zhou; Ning Xu
Journal:  Anal Cell Pathol (Amst)       Date:  2021-07-13       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.